Redhill Biopharma Ltd (RDHL US)

Analysis

Health Care • Israel

RedHill Biopharma is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. RedHill's pipeline includes several drug candidates in advanced clinical development stages, including three Phase III-stage programs. The company promotes GI products in the U.S.

Refresh

Exchange Announcement • 14 Oct 2026 04:06

424B5 | Prospectus

Exchange Announcement • 14 Jul 2026 18:00

424B3 | Prospectus

Exchange Announcement • 29 Jun 2026 19:00

424B5 | Prospectus

Exchange Announcement • 08 May 2026 05:00

424B5 | Prospectus

Exchange Announcement • 02 Feb 2026 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00